Also known as: 2-Propenamide, Acrylagel, Amresco Acryl-40, BRN 0605349, EINECS 201-173-7 (+8 more)
ACRYLAMIDE (CAS 79-06-1) is a cosmetic cosmetic ingredient functioning as Not Reported. NOAEL 0.5 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max II/681; GHS signal word DANGER. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety, pharmaceutical, and food safety data.
Auto-generated CPSR Part A draft with source citations
Cross-Vertical Regulatory Divergence
ACRYLAMIDE is classified GHS Danger (H301, H312, H315, H317, H319, H332, H340, H350) in the chemicals database but is restricted in EU cosmetics at max II/681.
For full compliance data across multiple jurisdictions, use the
Substance Compliance tool.
Safety Data
Margin of Safety, dermal absorption, and sensitization profile summaries for ACRYLAMIDE.
Calculate MoS for your specific formulation with the
MoS Calculator.
Toxicological Studies
10 study endpoints found for ACRYLAMIDE. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
Endpoint
Value
Route
Species
Study Type
Source
NOAEL
=0.00023 mg/kg bw/day
-
Rat
Toxicology study
WHO/JECFA
NOAEL
=0.00023 mg/kg bw/day
-
Rat
Toxicology study
WHO/JECFA
NOAEL
=0.003 mg/kg bw/day
oral
-
Toxicology study
WHO/JECFA
NOAEL
=0.003 mg/kg bw/day
oral
-
Toxicology study
WHO/JECFA
NOAEL
=0.00428571428571429 mg/kg bw/day
-
-
Toxicology study
WHO/JECFA
NOAEL
=0.00428571428571429 mg/kg bw/day
-
-
Toxicology study
WHO/JECFA
NOAEL
=0.006 mg/kg bw/day
-
-
Toxicology study
WHO/JECFA
NOAEL
=0.006 mg/kg bw/day
-
-
Toxicology study
WHO/JECFA
NOAEL
=0.088 mg/kg bw/day
oral
-
Toxicology study
WHO/JECFA
NOAEL
=0.088 mg/kg bw/day
oral
-
Toxicology study
WHO/JECFA
GHS Hazard Classification
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Signal Word
DANGER
Pictograms
SkullToxicCancerHealth haz
Hazard Statements
Toxic if swallowed Harmful in contact with skin or if inhaled Causes skin irritation Causes serious eye irritation May cause an allergic skin reaction May cause genetic defects May cause cancer Suspected of damaging fertility or the unborn child Causes damage to nervous system Causes damage to the nervous system through prolonged or repeated exposure
Short-term Exposure Effects
The substance is irritating to the eyes, skin and respiratory tract. The substance may cause effects on the nervous system. The effects may be delayed.
Long-term Exposure Effects
Repeated or prolonged contact may cause skin sensitization. The substance may have effects on the nervous system. This may result in peripheral nerve damage. This substance is probably carcinogenic to humans. May cause heritable genetic damage to human germ cells. May cause toxicity to human reproduction or development. Repeated or prolonged contact with skin may cause dermatitis. See Notes.
Routes of Exposure
The substance can be absorbed into the body by inhalation, through the skin and by ingestion.
Pre-Calculated Safety Assessment
Pre-calculated NOAEL → SED → MoS audit trail for ACRYLAMIDE across SCCS product categories, with measured dermal absorption where available.
EPA ToxValDB — Toxicity Values
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
Endpoint
Value
Species
Route
Duration
Source
cancer slope factor
=4.5 (mg/kg-day)-1
Human
inhalation
chronic
Cal OEHHA
cancer slope factor
=4.5 (mg/kg-day)-1
Human
oral
chronic
Cal OEHHA
LOEL
=0.05 mg/kg-day
Rat
oral
short-term
ECOTOX
LOEL
=10 mg/kg-day
Rat
oral
short-term
ECOTOX
LOEL
=5 mg/kg-day
Rat
oral
short-term
ECOTOX
MRL
=0.01 mg/kg-day
Human
oral
-
ATSDR MRLs
MRL
=0.001 mg/kg-day
Human
oral
-
ATSDR MRLs
MRL
=0.001 mg/kg-day
Human
oral
-
ATSDR MRLs
LOEL
=1.05 mg/kg-day
Mouse
oral
chronic
WHO/JECFA
NOAEL
=0.67 mg/kg-day
Rat
oral
chronic
WHO/JECFA
IARC Carcinogenicity
International Agency for Research on Cancer (WHO) monograph evaluation.
IARC Group
2A
Volume
60, Sup 7
Evaluation Year
1994
NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
EU CLP Annex VI Harmonized Classification
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
Safety and regulatory annotations from PubChem (NCBI) aggregated sources.
Safety (7)
Carcinogen Classification
2A, probably carcinogenic to humans. (L135)
Source: Toxin and Toxin Target Database (T3DB)
Carcinogen Classification
Acrylamide | Group 2A: Probably carcinogenic to humans | Volume 60: (1994) Some Industrial Chemicals | Volume Sup 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, 1987; 440 pages; ISBN 92-832-1411-0 (out of print) | NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
Source: International Agency for Research on Cancer (IARC)
Carcinogen Classification
Acrylamide | TR-575: Toxicology and Carcinogenesis Studies of Acrylamide (CASRN 79-06-1) in F344/N Rats and B6C3F1 Mice (Feed and Drinking Water Studies) (2012 ) | 04/05/11 | Clear Evidence | Clear Evidence | Clear Evidence | Clear Evidence | Under the conditions of these 2-year drinking water studies, there was clear evidence of carcinogenic activity of acrylamide in male F344/N rats bas
Source: NTP Technical Reports
Evidence for Carcinogenicity
Cancer Classification: Group B2 Probable Human Carcinogen | In accordance with the Guidelines for Carcinogen Risk Assessment (U.S. EPA, 2005, 086237), acrylamide (AA) is characterized as "likely to be carcinogenic to humans." This characterization is based on the following findings: (1) chronic oral exposure of F344 rats to AA in drinking water induced statistically significant increased incidence
Source: Hazardous Substances Data Bank (HSDB)
Endocrine Disruptors
Potential endocrine disrupting compound
Source: NORMAN Suspect List Exchange
Regulatory (1)
JECFA Evaluation
ACRYLAMIDE | 2011 | While adverse neurological effects are unlikely at the estimated average exposure, morphological changes in nerves cannot be excluded for individuals with a high dietary exposure to acrylamide. For a compound that is both genotoxic and carcinogenic, these MOEs indicate a health concern. The Committee noted that mitigation after 2003 has been reported for food types with high ac
Source: WHO/JECFA
Function Categories & List Membership
Cosmetic/Chemical Function Categories
No specific technical function
Regulatory List Membership (4)
California Proposition 65 (OEHHA)EU Banned in CosmeticsFDA Indirect Food Contact AdditivesEU CosIng Cosmetics Ingredient Database
Expert Verdict
Expert safety assessment and concern-level summary for ACRYLAMIDE.
ACRYLAMIDE has a safety rating of "MODERATE" in our database. EU status: restricted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Is ACRYLAMIDE allowed in the EU?
ACRYLAMIDE EU regulatory status: restricted. Maximum allowed concentration: II/681. This is based on EU Regulation 1223/2009 and its amendments.
What does ACRYLAMIDE do in cosmetics?
ACRYLAMIDE functions as: Not Reported. It is classified as a cosmetic ingredient in our database. CAS number: 79-06-1.
What is the NOAEL for ACRYLAMIDE?
The NOAEL (No Observed Adverse Effect Level) for ACRYLAMIDE is =0.00023 mg/kg bw/day based on a Toxicology study study via oral route in Rat. A total of 10 study endpoints are available. Source: WHO/JECFA.
Is ACRYLAMIDE classified as hazardous under GHS?
ACRYLAMIDE carries a GHS signal word of "DANGER". Hazard statements: Toxic if swallowed Harmful in contact with skin or if inhaled Causes skin irritation Causes serious eye irritation May cause an allergic skin reaction May cause genetic defects May cause cancer Suspected of damaging fertility or the unborn child Causes damage to nervous system Causes damage to the nervous system through prolonged or repeated exposure. This classification is based on the ILO/WHO International Chemical Safety Card and ECHA C&L inventory data. Note: GHS classification applies to the pure substance — at cosmetic use concentrations, hazard thresholds may not be met.
Is ACRYLAMIDE used outside cosmetics?
ACRYLAMIDE also appears in industrial chemical safety, pharmaceutical, and food safety data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Does ACRYLAMIDE have different safety status in cosmetics vs industrial chemicals?
ACRYLAMIDE is classified GHS Danger (H301, H312, H315, H317, H319, H332, H340, H350) in the chemicals database but is restricted in EU cosmetics at max II/681.
Compliance Tools
Check ACRYLAMIDE compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.